{"altmetric_id":2106569,"counts":{"readers":{"mendeley":32,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["jgarnettTSC"],"posts_count":1}},"selected_quotes":["@MaverickNY Good strategy on PARPi with predictive biomarkers. PI3Ki and PARPi also was interesting to me"],"citation":{"abstract":"Analyses of in vitro and patient-derived in vivo models of breast cancer reveal that a combination of inhibitors of the enzymes PARP and phosphoinositide 3-kinase (PI3K) is a potentially effective treatment regimen for breast cancer tumors with elevated activity of the PI3K pathway.","abstract_source":"pubmed","altmetric_jid":"4f6fa6103cf058f610006dcb","doi":"10.1158\/2159-8290.cd-12-0433","first_seen_on":"2014-02-07T20:54:29+00:00","funders":["wellcome","cruk"],"issns":[],"journal":"Cancer Discovery","last_mentioned_on":1391806463,"links":["http:\/\/m.cancerdiscovery.aacrjournals.org\/content\/2\/11\/982.full"],"pmid":"23148373","pubdate":"2012-11-15T00:00:00+00:00","subjects":["neoplasms"],"title":"The Promise of Combining Inhibition of PI3K and PARP as Cancer Therapy.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/promise-combining-inhibition-pi3k-parp-cancer-therapy"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":4010909,"mean":5.0312478775642,"rank":2245956,"this_scored_higher_than_pct":25,"this_scored_higher_than":1029831,"rank_type":"exact","sample_size":4010909,"percentile":25},"similar_age_3m":{"total_number_of_other_articles":117632,"mean":7.4729310300858,"rank":60517,"this_scored_higher_than_pct":27,"this_scored_higher_than":32192,"rank_type":"exact","sample_size":117632,"percentile":27},"this_journal":{"total_number_of_other_articles":826,"mean":5.0128436363636,"rank":398,"this_scored_higher_than_pct":33,"this_scored_higher_than":274,"rank_type":"exact","sample_size":826,"percentile":33},"similar_age_this_journal_3m":{"total_number_of_other_articles":25,"mean":12.593083333333,"rank":17,"this_scored_higher_than_pct":4,"this_scored_higher_than":1,"rank_type":"exact","sample_size":25,"percentile":4}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":18,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":3,"Student  > Postgraduate":1,"Other":3,"Student  > Master":2,"Student  > Bachelor":2},"by_discipline":{"Engineering":1,"Medicine and Dentistry":6,"Physics and Astronomy":1,"Agricultural and Biological Sciences":18,"Business, Management and Accounting":1,"Biochemistry, Genetics and Molecular Biology":5}}},"geo":{"twitter":{"US":1},"mendeley":{"US":1,"GB":1,"DE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/jgarnettTSC\/status\/431893728924405760","license":"public","citation_ids":[2106569],"posted_on":"2014-02-07T20:54:23+00:00","author":{"name":"Jeannine Garnett","image":"https:\/\/pbs.twimg.com\/profile_images\/462670822805499904\/ApoYzU1R_normal.jpeg","id_on_source":"jgarnettTSC","tweeter_id":"46800201","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":479},"tweet_id":"431893728924405760"}]}}